US Patent 7939257 Polymorphic GHSR nucleic acids and uses thereof
Patent 7939257 was granted and assigned to Third Wave Technologies on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+314 characters)
Article
Patent abstract
The present invention relates to methods and compositions for predicting the risk of obesity. In particular, the present invention provides methods and compositions for determining a subject's risk of obesity based on the presence of polymorphisms in the growth hormone secretagogue receptor (GHSR).
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07939257 Polymorphic GHSR nucleic acids and uses thereof US Patent 7939257 Polymorphic GHSR nucleic acids and uses thereof
Infobox
Patent Number
0793925700
Patent Number
793925700
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079392570
Date of Patent
May 10, 2011
0Patent Application Number
119143260
Date Filed
May 12, 2006
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079392570
Date of Patent
May 10, 2011
0Patent Application Number
119143260
Date Filed
May 12, 2006
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07939257 Polymorphic GHSR nucleic acids and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07939257
Date of patent
May 10, 2011
Patent application number
11914326
Date Filed
May 12, 2006
Patent primary examiner
Find more entities like US Patent 7939257 Polymorphic GHSR nucleic acids and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.